VivoSeq
Other

Osteoradionecrosis

3

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Osteoradionecrosis is an early-stage landscape with 3 programs across 0 companies. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

33/100

Pipeline

Programs by Phase

Analysis

Trial Status

3

clinical trials

Terminated1 · 33%
Completed1 · 33%
Recruiting1 · 33%

Clinical Trials

Trial Activity

Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis
Terminated·RRadboud University Medical Center·Phase 2/3·NCT00989820·20 enrolled
Osteoradionecrosis and PENTOCLO Protocol: Retrospective Study
Completed·UUniversity Hospital, Brest·N/A·NCT04097847·96 enrolled
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
Recruiting·SSunnybrook Health Sciences Centre·Phase 3·NCT06055257·24 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)